These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11495581)

  • 1. Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]piperazine-1-sulfonic acid dimethylamide.
    Mylari BL; Oates PJ; Beebe DA; Brackett NS; Coutcher JB; Dina MS; Zembrowski WJ
    J Med Chem; 2001 Aug; 44(17):2695-700. PubMed ID: 11495581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines.
    Chu-Moyer MY; Ballinger WE; Beebe DA; Berger R; Coutcher JB; Day WW; Li J; Mylari BL; Oates PJ; Weekly RM
    J Med Chem; 2002 Jan; 45(2):511-28. PubMed ID: 11784155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action: 1-(R)-[4-[4-(4,6-dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl]ethanol.
    Mylari BL; Oates PJ; Zembrowski WJ; Beebe DA; Conn EL; Coutcher JB; O'Gorman MT; Linhares MC; Withbroe GJ
    J Med Chem; 2002 Sep; 45(20):4398-401. PubMed ID: 12238919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol.
    Mylari BL; Withbroe GJ; Beebe DA; Brackett NS; Conn EL; Coutcher JB; Oates PJ; Zembrowski WJ
    Bioorg Med Chem; 2003 Sep; 11(19):4179-88. PubMed ID: 12951149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.
    Obrosova IG; Fathallah L; Lang HJ
    Biochem Pharmacol; 1999 Dec; 58(12):1945-54. PubMed ID: 10591149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor.
    Kador PF; Inoue J; Blessing K
    J Ocul Pharmacol Ther; 2004 Aug; 20(4):333-44. PubMed ID: 15321028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Yarasheski KE; Smith SR; Williamson JR; Peterson RG; Oates PJ
    Exp Neurol; 2005 Apr; 192(2):407-19. PubMed ID: 15755558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participants.
    Landau Z; Novotny MJ; Preston GM; Wright K; Freeman T; Dai H; Thompson J; Oates PJ; Calle RA
    J Clin Pharmacol; 2010 May; 50(5):521-30. PubMed ID: 20220044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
    Obrosova IG; Fathallah L; Lang HJ; Greene DA
    Diabetologia; 1999 Oct; 42(10):1187-94. PubMed ID: 10525658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
    Tilton RG; Chang K; Nyengaard JR; Van den Enden M; Ido Y; Williamson JR
    Diabetes; 1995 Feb; 44(2):234-42. PubMed ID: 7859946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711.
    Chu-Moyer MY; Ballinger WE; Beebe DA; Coutcher JB; Day WW; Li J; Oates PJ; Weekly RM
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1477-80. PubMed ID: 12031323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
    Ng TF; Lee FK; Song ZT; Calcutt NA; Lee AY; Chung SS; Chung SK
    Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium.
    Hwang YC; Bakr S; Ellery CA; Oates PJ; Ramasamy R
    FASEB J; 2003 Dec; 17(15):2331-3. PubMed ID: 14525943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity].
    Efimov AS; Obrosova IG; Velikiĭ NN
    Probl Endokrinol (Mosk); 1984; 30(2):71-6. PubMed ID: 6425821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorbitol-accumulating pyrimidine derivatives.
    Geisen K; Utz R; Grötsch H; Lang HJ; Nimmesgern H
    Arzneimittelforschung; 1994 Sep; 44(9):1032-43. PubMed ID: 7986240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor.
    Kuruvilla R; Eichberg J
    J Neurochem; 1998 Aug; 71(2):775-83. PubMed ID: 9681469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.